VYNE Therapeutics (VYNE) Change in Account Payables (2017 - 2019)
VYNE Therapeutics (VYNE) posted Change in Account Payables of $779000.0 for Q4 2019, up 145.5% on a QoQ basis from -$1.7 million in Q3 2019, and up 33.16% year-over-year from $585000.0 in Q4 2018.
VYNE Therapeutics (VYNE) Change in Account Payables (2017 - 2019) Analysis & Trends
VYNE Therapeutics' Change in Account Payables history runs 3 years deep, the most recent figure standing at $779000.0 for Q4 2019.
- Quarterly Change in Account Payables rose 33.16% year-over-year to $779000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $481000.0 (down 41.7% YoY) and the FY2019 annual result came in at $481000.0, down 41.7% from the prior year.
- Change in Account Payables was $779000.0 for Q4 2019 at VYNE Therapeutics, up from -$1.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.6 million in Q2 2018 and bottomed at -$2.4 million in Q3 2018.
- A 3-year average of $160500.0 and a median of $682000.0 in 2018 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 442.9% in 2018, while the deepest fall reached 256.69% in 2018.
- VYNE Therapeutics' Change in Account Payables stood at -$1.4 million in 2017, then soared by 142.36% to $585000.0 in 2018, then soared by 33.16% to $779000.0 in 2019.
- Business Quant data shows VYNE's Change in Account Payables at $779000.0 in Q4 2019, -$1.7 million in Q3 2019, and $921000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 779,000.00 |
| Dec 31, 2019 | 779,000.00 |
| Sep 30, 2019 | -1.71 Mn |
| Sep 30, 2019 | -1.71 Mn |
| Jun 30, 2019 | 921,000.00 |
| Jun 30, 2019 | 921,000.00 |
| Mar 31, 2019 | 493,000.00 |
| Mar 31, 2019 | 493,000.00 |
| Dec 31, 2018 | 585,000.00 |
| Dec 31, 2018 | 585,000.00 |
| Sep 30, 2018 | -2.39 Mn |
| Sep 30, 2018 | -2.39 Mn |
| Jun 30, 2018 | 1.59 Mn |
| Jun 30, 2018 | 1.59 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Dec 31, 2017 | -1.38 Mn |
| Dec 31, 2017 | -1.38 Mn |
| Sep 30, 2017 | 1.52 Mn |
| Sep 30, 2017 | 1.52 Mn |